<DOC>
	<DOC>NCT02805153</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of PEG-rhG-CSF in patients with breast cancer receiving chemotherapy</brief_summary>
	<brief_title>PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Patients with age between 18 and 70 years diagnosis of breast cancer patients chemotherapy naive Karnofsky Performance Status â‰¥ 70 Written informed consent are acquired uncontrolled infection Have accepted radiotherapy within 4 weeks before anticipated the study pregnancy Other situations that investigators consider as contraindication for this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>PEG-rhG-CSF</keyword>
</DOC>